Results 11 to 20 of about 12,858 (260)

Pasture Types and Echinococcus multilocularis, Tibetan Communities [PDF]

Emerging Infectious Diseases, 2006
Our study showed that open pastures had more small mammal burrows than fenced pastures in Tibetan pastoralist communities in 2003. This characteristic was linked to a higher prevalence of Echinococcus multilocularis in dogs and indicates that pasture ...
Qian Wang, Dominique A. Vuitton, Yongfu Xiao, Christine M. Budke, Maiza Campos-Ponce, Peter M. Schantz, Francis Raoul, Wen Yang, Philip S. Craig, Patrick Giraudoux   +9 more
doaj   +6 more sources

Detection of Echinococcus multilocularis in carnivores in Razavi Khorasan province, Iran using mitochondrial DNA. [PDF]

PLoS Neglected Tropical Diseases, 2011
BACKGROUND: Echinococcus multilocularis is the source of alveolar echinococcosis, a potentially fatal zoonotic disease. This investigation assessed the presence of E.
Molouk Beiromvand, Lame Akhlaghi, Seyed Hossein Fattahi Massom, Iraj Mobedi, Ahmad Reza Meamar, Hormozd Oormazdi, Abbas Motevalian, Elham Razmjou   +7 more
doaj   +3 more sources

First detection of Echinococcus multilocularis in golden jackals (Canis aureus) in Bosnia and Herzegovina [PDF]

International Journal for Parasitology: Parasites and Wildlife
Echinococcus multilocularis, the causative agent of alveolar echinococcosis (AE), is a parasitic zoonosis of increasing public health significance in Europe.
Naida Kapo, Jasmin Omeragić, Azra Bačić, Šejla Goletić, Adis Softić, Vedad Škapur, Toni Eterović, Jasna Salkić, Teufik Goletić   +8 more
doaj   +2 more sources

Echinococcus multilocularis in Estonia

Emerging Infectious Diseases, 2005
To the Editor: Alveolar echinococcosis (AE) caused by Echinococcus multilocularis is one of the most important emerging zoonosis in Europe. The fatality rate is >90% in untreated patients (1). In Europe, the distribution range of the zoonotic tapeworm E.
Epp Moks, Urmas Saarma, Harri Valdmann
doaj   +3 more sources

Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection

Frontiers in Immunology
BackgroundCurrent treatments and prevention strategies for echinococcosis are inadequate. Recent advancements in molecular vaccine development show promise against Echinococcus granulosus; however, Echinococcus multilocularis remains a challenge. A Multi-
Yichen Fan, Yueyue He, Yujiao Li, Zhengwei Yin, Juan Shi, Tingting Tian, Kaiyu Shang, Huidong Shi, Fengbo Zhang, Fengbo Zhang, Hao Wen   +10 more
doaj   +3 more sources

The immunodiagnosis of Echinococcus multilocularis infection [PDF]

Clinical Microbiology and Infection, 2007
Alveolar echinococcosis (AE) is a severe zoonotic disease caused by the metacestode stage of Echinococcus multilocularis. The infection can have fatal consequences in humans if treatment is not provided, so early diagnosis is fundamental for initiating treatment and reducing morbidity and mortality.
Carmena, D., Benito, A., Eraso, E.
openaire   +4 more sources

Host Proteins in <i>Echinococcus multilocularis</i> Metacestodes. [PDF]

Int J Mol Sci
Metacestodes of Echinococcus multilocularis are the causative agents of alveolar echinococcosis, a neglected, life-threatening, zoonotic disease. To study these metacestodes in vitro, a model system using a culture medium conditioned by rat hepatoma cells is available. A key question is how the parasite interacts with the host and, in particular, which
Müller J, Zumkehr B, Heller M, Uldry AC, Braga-Lagache S, Lundström-Stadelmann B.   +5 more
europepmc   +3 more sources

Annual assessment of <i>Echinococcus multilocularis</i> surveillance reports submitted in 2025 in the context of Commission Delegated Regulation (EU) 2018/772. [PDF]

EFSA J
Abstract This report comprises the 15th assessment of the Echinococcus multilocularis surveillance scientific reports, provided by Finland, Ireland, the United Kingdom (Northern Ireland) and Norway on their respective surveillance programmes. Every year since 2012, EFSA presents the assessment to the European Commission in which the sampling strategy ...
European Food Safety Authority (EFSA), Zancanaro G, Papaleo S.   +2 more
europepmc   +2 more sources

Echinococcus multilocularis in Illinois and Nebraska

The Journal of Parasitology, 1983
Argentation-TLC showed that cholesterol was the only free sterol present in the ES products of 7to 21-day-old worms. Barrett et al. (1970, J. Parasitol. 56: 10041008) using GLC showed that cholesterol comprised 95% of the sterols, cholestane 2.5% and unidentified lipids the other 2.5% in E. revolutum adults.
Neil B. Ballard, Frederick J. Vande Vusse   +1 more
openalex   +3 more sources

High PD-1 and CTLA-4 expression correlates with host immune suppression in patients and a mouse model infected with Echinococcus multilocularis [PDF]

Parasites & Vectors
Background Alveolar echinococcosis (AE), a fatal disease caused by Echinococcus multilocularis, often affects the liver, with tumor-like growth. However, the mechanism by which E. multilocularis evades host immune surveillance remains unclear. Methods We
Ting Sun, Yi Yang, Yiwen Qiu, Tao Wang, Ming Yang, Shu Shen, Wentao Wang   +6 more
doaj   +2 more sources